Celgene Fights Investors' Class Cert. Bid In Stock-Drop Suit
Celgene Corp. Inc. is urging a New Jersey federal court to reject a Swedish investor's bid to certify a proposed class action claiming the biopharmaceutical company artificially inflated its share price...To view the full article, register now.
Already a subscriber? Click here to view full article